在利多卡因中加入不同添加剂用于下牙槽神经阻滞的麻醉效果:一项系统评价与Meta分析及试验序贯分析
该系统评价纳入14项随机对照试验,评估在利多卡因中加入添加剂对下牙槽神经阻滞成功率的影响。正常牙髓组(307例)和症状性不可逆性牙髓炎组(434例)中,加入添加剂均未显著提高成功率;证据质量分别为极低和低。
要点
- 正常牙髓组加入添加剂无显著效果(RR 0.84,95%CI 0.53-1.32,I²=98%)。
- 症状性不可逆性牙髓炎组加入添加剂无显著效果(RR 1.22,95%CI 0.98-1.52,I²=0%)。
- 试验序贯分析显示各组结局均为「不确定」,证据质量极低至低。
核心结论
- 极低至低的证据质量表明,在利多卡因中加入添加剂并未提高下牙槽神经阻滞的疗效,仍需补充注射以帮助从业者实现无痛牙科治疗。
研究设计与样本
- 系统评价与Meta分析及试验序贯分析,检索PubMed、Scopus、Web of Science、Ovid、EBSCO、Embase和Cochrane数据库至2021年12月1日,纳入14项随机对照试验(正常牙髓组8项,症状性不可逆性牙髓炎组6项)。
主要发现
- 正常牙髓组307例参与者中,加入添加剂无显著效果(RR 0.84,95%CI 0.53-1.32,I²=98%)。
- 正常牙髓组亚组分析中,加入甘露醇导致更高的成功率(RR 1.24,95%CI 1.15-1.34,I²=7.16%)。
- 症状性不可逆性牙髓炎组434例参与者中,加入添加剂无显著效果(RR 1.22,95%CI 0.98-1.52,I²=0%)。
- 症状性不可逆性牙髓炎组亚组分析中,加入甘露醇或碳酸氢钠均无显著效果(RR 1.76,95%CI 0.93-3.32,I²=18.41%;RR 1.06,95%CI 0.65-1.72,I²=53.5%)。
- 试验序贯分析显示各组结局均为「不确定」,证据质量正常牙髓组为「极低」,症状性不可逆性牙髓炎组为「低」。
临床怎么用
- 作者结论认为,在利多卡因中加入添加剂未提高下牙槽神经阻滞的疗效,仍需补充注射以帮助从业者实现无痛牙科治疗。
局限性
- 试验序贯分析显示各组结局均为「不确定」。
- 证据质量正常牙髓组为「极低」,症状性不可逆性牙髓炎组为「低」。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Incorporating an additive into lidocaine is a method to enhance the efficacy of the inferior alveolar nerve block (IANB) in mandibular posterior teeth. OBJECTIVES: To assess the efficacy of incorporating additives into lidocaine in the success rate of IANB for teeth with the diagnosis of normal pulp (NP) or symptomatic irreversible pulpitis (SIP). METHODS: Randomized controlled trials (RCTs) assessing the incorporation of additives into lidocaine on the pulpal anaesthesia success rate of mandibular posterior teeth were searched in PubMed, Scopus, Web of Science, Ovid, EBSCO, Embase, and Cochrane databases up to 1 December 2021. The risk of bias (RoB) was assessed by the Cochrane Risk of Bias Tool. A random-effects model was employed to calculate the pooled risk ratio (RR) with a 95% confidence interval (CI), using STATA 16. The trial sequential analysis (TSA) was applied to calculate the required information size (RIS). The Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach was used to assess the certainty of the evidence. RESULTS: Of 6966 records retrieved initially, 14 trials (8 for NP and 6 for SIP groups) were included in qualitative and quantitative syntheses. All trials were categorized as low and unclear RoB for NP and SIP groups, respectively. In the NP group, with 307 participants, no significant effect was observed for additives incorporated into lidocaine (RR: 0.84; 95% CI: 0.53-1.32; I2 = 98%). Subgroup analysis revealed that adding mannitol led to a higher success rate (RR = 1.24; 95% CI: 1.15-1.34; I2 = 7.16%). In the SIP group, with 434 participants, no significant effect was shown when the additives were incorporated (RR = 1.22; 95% CI: 0.98-1.52; I2 = 0%). Likewise, in subgroup analysis, incorporating mannitol or sodium bicarbonate demonstrated no significant effect (RR = 1.76; 95% CI: 0.93-3.32; I2 = 18.41% and RR = 1.06; 95% CI: 0.65-1.72; I2 = 53.5%, respectively). DISCUSSION: TSA revealed that the outcome was "inconclusive" for each group. The certainty of the evidence was graded as "very low" and "low" for NP and SIP groups, respectively. CONCLUSIONS: The very low to low certainty of evidence indicated that incorporating additives into lidocaine did not increase the efficacy of IANB and supplemental injections are still necessary to help practitioners achieve painless dentistry. REGISTRATION: PROSPERO database (CRD42020132585).
引用
- Iranmanesh P, Khazaei S, Nili M, et al. Anaesthetic efficacy of incorporating different additives into lidocaine for the inferior alveolar nerve block: A systematic review with meta-analysis and trial sequential analysis. Int Endod J. 2022. PMID: 35398916. doi:10.1111/iej.13746
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。